ReviewFrontiers in cellular and infection microbiology2026
Cellular signaling meets bacterial infection: the integrative role of STAT3.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
STAT3 is a central mediator of pro-survival signaling within the STAT family, functioning through both canonical transcriptional activity and noncanonical mechanisms. As a pleiotropic regulator, STAT3 integrates cytokine, growth factor, and stress signals to coordinate diverse cellular processes, including epithelial architecture, T cell development, macrophage polarization, apoptosis, metabolism, and inflammation-associated wound healing. This integrative capacity positions STAT3 as a critical signaling hub at the interface of tissue homeostasis and immune regulation. Dysregulated STAT3 activity is strongly associated with cancer and chronic inflammatory disease. Notably, an increasing number of bacterial pathogens exploit STAT3 to facilitate infection and persistence. By targeting this central hub, pathogens reprogram host survival, metabolic, and immune pathways to create a permissive intracellular environment. In this review, we examine the molecular architecture of STAT3 signaling, its role in coordinating cellular programs, and the diverse mechanisms by which bacterial pathogens, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.